Atlas Trials

T-Control® Safety for Cytostatics Management

Clinical trial NCT06678633 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06678633
Sponsor
Rethink Medical SL
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Non-muscle-invasive Bladder Cancer
Start date
2025-11-01
Primary completion
2026-11-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.